This page shows the latest Turnstone Biologics news and features for those working in and with pharma, biotech and healthcare.
have tied up with Turnstone Biologics and BeneVir Biopharm, respectively.
Companies such as AbbVie and J&J both struck deals in the field last year with biotech firms – Turnstone Biologics and BeneVir Biopharm respectively.
More from news
Approximately 0 fully matching, plus 2 partially matching documents found.
targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’ CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
He joins the immuno-oncology group as its president of R&D. Turnstone Biologics, a North American clinical-stage immuno-oncology company, has appointed Dr Mike Burgees as its president of ... He said: “ Turnstone Biologics is uniquely positioned to
Kris Elverum and José Otero join the group. Canadian immuno-oncology company Turnstone Biologics has strengthened its leadership team with the addition of two new hires. ... Sammy Farah, chief executive officer, Turnstone Biologics, said: “The
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...